Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of CKD-320 vs D012 in Healthy Subjects
NCT04035538Phase 1Unknown
- Sponsor
- Chong Kun Dang Holdings
- Start
- Aug 2019
- Primary completion
- Nov 2019
01
Overview
Phase 1, randomised, open-label trial of CKD-320 in hypertension (HTN) (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Area Under the Concentration-time Curve from time zero to the last measurable concentration and Maximum Plasma Concentration. Status: unknown.
02
Drugs
CKD-320
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04035538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04035538.